Seres Therapeutics, Inc.

Go to Seres Therapeutics, Inc. Website

$14.25

-0.03 (-0.21%)
Live
Previous Close

$14.28

Day Range

$14.01 - $14.71

Previous Day Range

$14.11 - $15.38

Market Cap

$129.1 million USD

Day Vol.

12818

Previous Day Vol.

147475

Currency

USD

Primary Exchange

Nasdaq

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company ar...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Denodo, a leader in data management, has announced the Denodo University Challenge, 'Data and AI for Real-World Impact', which aims to encourage students to develop innovative AI-driven solutions that have a demonstrable impact on social and economic challenges. The challenge will leverage Denodo's data management and AI tools, including the Denodo Platform and the Denodo AI SDK.

Related tickers: MCRB.

Read Full Article

Seres Therapeutics presented new exploratory biomarker data from its SER-155 Phase 1b study, showing evidence of improved intestinal epithelial barrier integrity, modulation of systemic inflammatory responses, and potential to promote immune reconstitution after allogeneic hematopoietic stem cell transplant.

Related tickers: MCRB.

Read Full Article
Trending Tickers

Please sign in to view